^
CANCER:

Salivary Gland Cancer





Show legend
Group by Gene:
0
Tubulin polymerization promoter
paclitaxel
carboplatin + paclitaxel
1
Androgen receptor antagonist
bicalutamide
2
GnRH agonist
leuprolide acetate
3
Tubulin polymerization promoter, DNA synthesis inhibitor
carboplatin + gemcitabine
4
HER2 inhibitor
trastuzumab
ACE1702
5
TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
larotrectinib
6
HER2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
fam-trastuzumab deruxtecan-nxki
7
HER2 inhibitor, HER2 dimerization inhibitor
trastuzumab + pertuzumab
8
RET inhibitor
selpercatinib
pralsetinib
9
FGFR inhibitor
ABSK091
10
CXCL12 inhibitor, Farnesyl transferase inhibitor
tipifarnib
11
VEGFR-2 inhibitor
vandetanib
12
ALK inhibitor, Multi-tyrosine kinase inhibitor
crizotinib + pazopanib
13
AKT inhibitor
AZD5363
14
PD1 inhibitor
pembrolizumab
PD1 inhibitor
15
CYP17A1 inhibitor
abiraterone acetate
16
Hedgehog cell-signalling pathway inhibitor
vismodegib
17
Topoisomerase II inhibitor, Alkylating agent, DNA synthesis inhibitor
cisplatin + doxorubicin hydrochloride + cyclophosphamide
18
Tubulin polymerization inhibitor, DNA synthesis inhibitor
cisplatin + vinorelbine tartrate
19
TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor
entrectinib
20
Androgen receptor antagonist, GnRH agonist
leuprolide acetate + bicalutamide
21
HER2-targeted antibody-drug conjugate, Microtubule inhibitor
ado-trastuzumab emtansine
ARX788
22
HER2 inhibitor, EGFR inhibitor
pyrotinib
No biomarker
AR positive
HER-2 amplification
HER-2 positive
HER-2 overexpression
HER-2 expression
HER-2 amplification + HER-2 mutation
PD-L1 expression
NTRK3 fusion
RET fusion
PTEN expression
PTCH1 mutation
NTRK1 fusion
BAG4-FGFR1 B2F6
ETV6-NTRK3 fusion
MET N375S
PLIN2 expression
AR positive + HER-2 amplification
AKT1 E17K
PIK3CA H1047R
HRAS mutation
NTRK2 fusion